- Home
- PLUR vs BTTC Comparison
PLUR vs BTTC Comparison
Compare PLUR & BTTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- BTTC
- Stock Information
- Founded
- PLUR 2001
- BTTC 1990
- Country
- PLUR Israel
- BTTC Malaysia
- Employees
- PLUR N/A
- BTTC N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- BTTC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PLUR Health Care
- BTTC Health Care
- Exchange
- PLUR Nasdaq
- BTTC Nasdaq
- Market Cap
- PLUR 36.9M
- BTTC 40.5M
- IPO Year
- PLUR N/A
- BTTC N/A
- Fundamental
- Price
- PLUR $3.95
- BTTC $2.95
- Analyst Decision
- PLUR Strong Buy
- BTTC
- Analyst Count
- PLUR 1
- BTTC 0
- Target Price
- PLUR $12.00
- BTTC N/A
- AVG Volume (30 Days)
- PLUR 52.1K
- BTTC 40.0K
- Earning Date
- PLUR 11-12-2025
- BTTC 01-01-0001
- Dividend Yield
- PLUR N/A
- BTTC N/A
- EPS Growth
- PLUR N/A
- BTTC N/A
- EPS
- PLUR N/A
- BTTC 0.72
- Revenue
- PLUR $1,326,000.00
- BTTC $2,719,480.00
- Revenue This Year
- PLUR $97.38
- BTTC N/A
- Revenue Next Year
- PLUR $293.97
- BTTC N/A
- P/E Ratio
- PLUR N/A
- BTTC $4.09
- Revenue Growth
- PLUR 121.74
- BTTC 2.04
- 52 Week Low
- PLUR $3.22
- BTTC $2.81
- 52 Week High
- PLUR $7.13
- BTTC $39.00
- Technical
- Relative Strength Index (RSI)
- PLUR 48.02
- BTTC N/A
- Support Level
- PLUR $3.50
- BTTC N/A
- Resistance Level
- PLUR $4.12
- BTTC N/A
- Average True Range (ATR)
- PLUR 0.37
- BTTC 0.00
- MACD
- PLUR 0.03
- BTTC 0.00
- Stochastic Oscillator
- PLUR 36.83
- BTTC 0.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About BTTC Black Titan Corporation Ordinary Shares
Black Titan Corp is engaged in software implementation and training. It provides consulting services and Human Resource and Payroll solutions.